Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial

Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS): study protocol for a prospective, randomized, double-blind, non-inferiority trial

Abstract Background Tranexamic acid (TXA) has been routinely delivered in multisegmental spinal decompression and bone graft fusion surgeries with satisfactory outcomes in minimizing gross blood loss and transfusion demands. However, concerns remain that intravenously delivered TXA (ivTXA) may incre...

Full description

Bibliographic Details
Main Authors: Shangyi Hui, Liyuan Tao, Feroze Mahmood, Derong Xu, Zhinan Ren, Xin Chen, Lin Sheng, Qianyu Zhuang, Shugang Li, Yuguang Huang
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Trials
Subjects:
Topical
Intravenous
Tranexamic acid
Spinal fusion
Blood loss
Non-inferiority trial
Online Access:http://link.springer.com/article/10.1186/s13063-019-3231-9

Internet

http://link.springer.com/article/10.1186/s13063-019-3231-9

Similar Items